pharmaphorum

UK-based pharmaceutical industry trade media

Background

Pharmaphorum was founded in 2009 by Dr. Paul Tunnah, an Oxford-trained biochemist, as an independent digital media outlet serving the global pharmaceutical industry. It grew to reach roughly 150,000 professional readers and became a prominent trade publication covering drug development, commercialization, and healthcare policy. In 2020, Healthware Group, an Italy-headquartered healthcare communications company, acquired pharmaphorum, with Tunnah staying on as Chief Content Officer and Managing Director UK. Healthware Group was itself acquired by EVERSANA, a large pharmaceutical services company, in October 2023, with the integration completing in April 2024. Pharmaphorum operates as a nominally editorially independent subsidiary of EVERSANA, though EVERSANA is itself a major player in the pharmaceutical industry being covered, raising inherent conflict-of-interest questions. The outlet publishes both independent editorial content and clearly labeled sponsored material, and has covered Trump administration drug-pricing moves — including Most-Favored-Nation pricing agreements and proposed tariffs on branded and generic drugs — in a largely straight-news style without overt advocacy.

Sources

1. About pharmaphorum
2. Healthware Group acquires pharmaphorum
3. EVERSANA acquires Healthware Group
4. EVERSANA Completes Integration of Healthware Group
5. Trump sets course for 100%, then 200%, tariffs on generics
6. Advertise on pharmaphorum

Profile compiled 2026-08-29; refreshed when ownership, funding, or the administration changes.

← Back to track record